CASE PRESENTATION: A 58-year-old man presented to the ED with a 1-week history of progressive weight loss, generalized weakness, unsteadiness, and dizziness. In hospital, he experienced a witnessed episode of loss of consciousness with no observable respirations that lasted for 15 minutes. His arterial blood gas demonstrated hypercapnic respiratory failure, and he required mask ventilation and vasoactive medications. Similar episodes occurred several more times over the course of the night that required the patient to be intubated. The paroxysmal episodes persisted necessitating continued invasive ventilatory support and admission to the ICU. The episodes occurred in both awake and asleep states and required the ventilator settings to dictate a minimum rate, but minimal ventilatory support otherwise. Further history revealed other symptomatic complaints of vertigo, dysphagia, and hypophonia that had progressed over a 2-month period. The patient's medical history was pertinent for a diagnosis of prostatic carcinoma 3 years previously that was found to be castrate resistant. He had metastases to his hip, ribs, and thoracic spine. Previous treatments had included bicalutamide, docetaxel, and abiraterone; he was receiving leuprolide therapy on presentation.
CASE PRESENTATION: A 58-year-old man presented to the ED with a 1-week history of progressive weight loss, generalized weakness, unsteadiness, and dizziness. In hospital, he experienced a witnessed episode of loss of consciousness with no observable respirations that lasted for 15 minutes. His arterial blood gas demonstrated hypercapnic respiratory failure, and he required mask ventilation and vasoactive medications. Similar episodes occurred several more times over the course of the night that required the patient to be intubated. The paroxysmal episodes persisted necessitating continued invasive ventilatory support and admission to the ICU. The episodes occurred in both awake and asleep states and required the ventilator settings to dictate a minimum rate, but minimal ventilatory support otherwise. Further history revealed other symptomatic complaints of vertigo, dysphagia, and hypophonia that had progressed over a 2-month period. The patient's medical history was pertinent for a diagnosis of prostatic carcinoma 3 years previously that was found to be castrate resistant. He had metastases to his hip, ribs, and thoracic spine. Previous treatments had included bicalutamide, docetaxel, and abiraterone; he was receiving leuprolide therapy on presentation.
Authors: F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre Journal: Brain Date: 2001-06 Impact factor: 13.501
Authors: Rahul Aggarwal; Jiaoti Huang; Joshi J Alumkal; Li Zhang; Felix Y Feng; George V Thomas; Alana S Weinstein; Verena Friedl; Can Zhang; Owen N Witte; Paul Lloyd; Martin Gleave; Christopher P Evans; Jack Youngren; Tomasz M Beer; Matthew Rettig; Christopher K Wong; Lawrence True; Adam Foye; Denise Playdle; Charles J Ryan; Primo Lara; Kim N Chi; Vlado Uzunangelov; Artem Sokolov; Yulia Newton; Himisha Beltran; Francesca Demichelis; Mark A Rubin; Joshua M Stuart; Eric J Small Journal: J Clin Oncol Date: 2018-07-09 Impact factor: 44.544
Authors: Manuel J Gómez-Choco; Juan J Zarranz; Albert Saiz; María I Forcadas; Francesc Graus Journal: J Neurol Neurosurg Psychiatry Date: 2007-10 Impact factor: 10.154
Authors: A Saiz; J Bruna; P Stourac; M C Vigliani; B Giometto; W Grisold; J Honnorat; D Psimaras; R Voltz; F Graus Journal: J Neurol Neurosurg Psychiatry Date: 2008-11-17 Impact factor: 10.154
Authors: A Storstein; M Raspotnig; R Vitaliani; B Giometto; F Graus; W Grisold; J Honnorat; C A Vedeler Journal: J Neurol Date: 2016-03-23 Impact factor: 4.849
Authors: John E Greenlee; Susan A Clawson; Kenneth E Hill; Blair Wood; Stacey L Clardy; Ikuo Tsunoda; Troy D Jaskowski; Noel G Carlson Journal: J Neuroinflammation Date: 2014-09-17 Impact factor: 8.322